ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,165.30
0.26%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.909
0.22%
Brent Oil
83.295
0.20%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Heart Test Laboratories Inc (HSCS)

  7. Heart Test Laboratories Inc (HSCS) ニュース

HSCS Heart Test Laboratories Inc

0.0908
-0.0037 (-3.92%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Heart Test Laboratories Inc HSCS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.0037 -3.92% 0.0908 13:00:08
始値 安値 高値 終値 前日終値
0.0942 0.088 0.0943 0.0888 0.0945
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2422:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
2024/4/0305:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
2024/3/2622:00GLOBEHeartSciences Announces Podium Presentation at World..
2024/3/1505:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
2024/3/1222:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
2024/3/0623:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
2024/3/0606:55EDGAR2Form S-1 - General form for registration of securities under..
2024/2/2707:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2623:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
2024/2/1606:30EDGAR2Form 8-K - Current report
2024/2/1223:00GLOBEHeartSciences Expands its Scientific Advisory Board
2024/2/0123:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
2024/1/3123:00EDGAR2Form 8-K - Current report
2024/1/2522:59EDGAR2Form 8-K - Current report
2024/1/1822:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/1822:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/1822:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
2024/1/1821:55EDGAR2Form 8-K - Current report
2024/1/0406:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
2023/12/1506:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
2023/12/1506:07EDGAR2Form 8-K - Current report
2023/12/1506:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/12/1407:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/1122:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/0907:14EDGAR2Form DEF 14A - Other definitive proxy statements
2023/12/0807:00EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
2023/12/0623:21EDGAR2Form 8-K - Current report
2023/12/0522:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
2023/11/2907:26EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/2806:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/2722:30EDGAR2Form 8-K - Current report
2023/11/2122:30EDGAR2Form 8-K - Current report
2023/11/2022:00GLOBEHeartSciences Announces Closing of License Agreements with..
2023/11/1806:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/1806:26EDGAR2Form 8-K - Current report
2023/11/1322:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
2023/10/1922:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
2023/10/1410:36EDGAR2Form S-1/A - General form for registration of securities..
2023/10/0506:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/2621:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
2023/9/2521:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
2023/9/2305:16EDGAR2Form 8-K - Current report
2023/9/2121:00EDGAR2Form 8-K - Current report
2023/9/2121:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
2023/9/1819:09EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/9/1505:24EDGAR2Form 8-K - Current report
2023/9/1505:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
2023/9/1505:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/9/1305:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
2023/9/1205:15GLOBEHeartSciences Named Electrocardiography Advancement..

最近閲覧した銘柄

NASDAQ
HSCS
Heart Test Laboratories
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有